UCAD for Diagnosing Benign or Malignant Gallbladder Diseases and Follow-up
NCT06232538 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2024-02-01
Summary
Copy number variation(CNV) refers to ongoing chromosome segregation errors throughout consecutive cell divisions. CNV is a hallmark of human cancer, and it is associated with poor prognosis, metastasis, and therapeutic resistance. Analyzing CNV of the DNA extracted from bile samples in gallbladder seems a promising method for diagnosing, monitoring, and predicting the prognosis of patients with gallbladder cancer. CNV can be assessed using experimental techniques such as bulk DNA sequencing, fluorescence in situ hybridization (FISH), or conventional karyotyping. However, these techniques are either time-consuming or non-specific. The investigators here intend to study whether a new method named Ultrasensitive Chromosomal Aneuploidy Detection (UCAD), which is based on low-coverage whole-genome sequencing, can be used to analyze CNV thus helping diagnose gallbladder cancer and assessing follow-up.
Conditions
- Gallbladder Cancer
Interventions
- DIAGNOSTIC_TEST
-
The level of CNV
The extracted DNA from bile will be analyzed by UCAD to determine the level of CNV. And the patient will be followed more than 1 year.
Sponsors & Collaborators
-
Shanghai Zhongshan Hospital
collaborator OTHER -
Ruijin Hospital
collaborator OTHER -
Changhai Hospital
collaborator OTHER -
Shanghai Changzheng Hospital
collaborator OTHER -
Eastern Hepatobiliary Surgery Hospital
collaborator OTHER -
First Affiliated Hospital Xi'an Jiaotong University
collaborator OTHER -
Jiangsu Provincial People's Hospital
collaborator OTHER -
Third Affiliated Hospital, Sun Yat-Sen University
collaborator OTHER -
First Affiliated Hospital of Zhejiang University
collaborator OTHER -
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
collaborator OTHER -
Second Hospital of Jilin University
collaborator OTHER -
West China Hospital
collaborator OTHER -
Southwest Hospital, China
collaborator OTHER -
Affiliated Hospital of North Sichuan Medical College
collaborator OTHER -
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
collaborator OTHER -
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2026-01-31
- Completion
- 2026-08-31
Countries
- China
Study Locations
More Related Trials
-
Diagnostic Value of Next-Generation Sequencing Analysis in Biliary Tract Tumours
NCT06729944 ·Status: RECRUITING ·Phase: NA
-
Clinical Correlation Study Between Anomalous Pancreaticobiliary Ductal Junction and Malignant Tumors of the Biliary System and the Establishment of an AI-based Automated Recognition System
NCT06903520 ·Status: COMPLETED
-
The Surveillance of Hepatocellular Carcinoma
NCT05286099 ·Status: UNKNOWN
-
Computer-Aided Diagnosis for Hepatocellular Carcinoma Microvascular Invasion
NCT07170345 ·Status: RECRUITING
-
National Liver Cancer Screening Trial
NCT06084234 ·Status: RECRUITING ·Phase: PHASE4
-
Biobank for Cholestatic Liver Diseases.
NCT03445585 ·Status: RECRUITING
-
Clinical Application of Quantitative Major Imaging Features of CEUS LI-RADS
NCT06590948 ·Status: RECRUITING
-
Biliary Obstruction of Neoplastic Origin Treated With Drainage. A Prognostic Study.
NCT06552208 ·Status: COMPLETED
-
The Influence of Antibiotics on the Incidence of Biliary Tract Infections After PTCD for Malignant Obstructive Jaundice
NCT04620577 ·Status: UNKNOWN
-
Exploration of Noninvasive Differential Diagnosis of Benign and Malignant Liver Tumors
NCT06524557 ·Status: RECRUITING
-
CT Image-assisted Detection Software for Focal Liver Lesions
NCT06068413 ·Status: COMPLETED ·Phase: NA
-
Effectiveness and Safety of the COVID-19 Vaccination for Patients With Liver Disease (CHESS2101)
NCT04883177 ·Status: COMPLETED
-
Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC
NCT04212286 ·Status: COMPLETED ·Phase: NA
-
Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
NCT02917408 ·Status: COMPLETED
-
Congenital Biliary Dilatation Diagnosis Based on 3D Morphological Characteristics
NCT06162520 ·Status: COMPLETED
-
Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis
NCT06781242 ·Status: RECRUITING
-
Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma
NCT02730611 ·Status: COMPLETED
-
Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE)
NCT06277531 ·Status: RECRUITING
-
Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis
NCT04288323 ·Status: COMPLETED ·Phase: PHASE4
-
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
NCT03894917 ·Status: RECRUITING
-
Familial Intrahepatic Cholestasis-related Genes Associated with Disease Susceptibility in Hepato-biliary Cancers
NCT06777914 ·Status: RECRUITING
-
PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobiliary System in Patients With Primary Biliary Cholangitis Before and After Treatment.
NCT06604923 ·Status: ACTIVE_NOT_RECRUITING
-
Nomogram for Predicting Biliary Complication
NCT06658665 ·Status: NOT_YET_RECRUITING
-
Radiomics Analysis of Focal Liver Lesions Based on Contrast-Enhanced Ultrasound Imaging
NCT04682886 ·Status: RECRUITING
-
Extracellular RNA Markers of Liver Disease and Cancer
NCT02908048 ·Status: TERMINATED